Level C· Early human research exploring benefitsCase Report / SeriesPubMedOpen access

Does intra-articular injection of adipose-derived stem cells improve cartilage mass? A case report using three-dimensional image analysis software in knee osteoarthritis.

Kuwasawa A., Nihei K.

Case Report / Series on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in J Med Case Rep (2021) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
J Med Case Rep (2021)
Country
England
Reported sample size
—
Source database
PubMed
PMID
34920759
PMCID
PMC8684096
DOI
10.1186/s13256-021-03186-6

Abstract (original English)

Background Mesenchymal stem cells are currently a research focus because of the possibility of cartilage regeneration through several mechanisms, including mesenchymal stem cell sheets. However, there are no published reports visualizing cartilage in three dimensions. Here, we report a case of improved cartilage volume. We purified and cultured adipose-derived mesenchymal stem cells and then performed adipose-derived mesenchymal stem cell therapy by directly injecting these cells into the articular cartilage. Cartilage was quantitatively evaluated before and after injection using three-dimensional image analysis software based on the magnetic resonance imaging. Case presentation The patient, a 55-year-old Japanese woman, experienced pain in both knees and was diagnosed with osteoarthritis of the knee. We performed adipose-derived mesenchymal stem cell therapy in both knees at our hospital and quantitatively evaluated cartilage before and after the treatment using the three-dimensional image analysis software "SYNAPSE VINCENT". Conclusions Preoperatively, the cartilage defect area was 33.59 mm 2 in the femur and 122.31 mm 2 in the tibia; however, 12 months postoperatively, it improved to 13.59 mm 2 and 51.43 mm 2 , respectively. Furthermore, the preoperative femur and tibia volumes were 9.58 mL and 3.82 mL, respectively; however, 12 months postoperatively, these values improved

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
CartilageHumansImaging, Three-DimensionalInjections, Intra-ArticularMiddle AgedOsteoarthritis, KneeReproducibility of ResultsSoftwareStem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research